Our Experts

jay-shah-headshot

Jay Shah

Director, GTM Solution Consultant

Expertise: Commercial Strategy, Product Launch, Marketing and Promotion, Real-World Data

Jay Shah is the director of GTM Solution Consulting at MMIT. He leads cross-functional initiatives to strengthen enablement, drive pricing and packaging innovation, and align product development with evolving market needs. Jay has worked in healthcare intelligence for more than a decade, supporting strategic initiatives in data transformation, supplementation, and segmentation. He holds a bachelor’s degree in Industrial Engineering from California State Polytechnic University-Pomona.

Insights by Jay Shah

Article | October 23, 2025

Tracking the Real-World Impact of Payer Policies on Patient Outcomes

In today’s complex pharmaceutical landscape, a brand’s market access can no longer be judged solely by its coverage. Pharma leaders are under growing pressure not just to identify access barriers, but to prove their impact.

Article | February 27, 2025

Promoting Your Brand: Six Steps for Success

Months and months of market access planning occur long before a new therapy is approved. Once that therapy is finally on the market, pharma companies must then turn their attention to the art of effective brand promotion.

On-Demand Webinar | February 25, 2025

Promotional Strategies

In this webinar, our experts share best practices for engaging physicians both in person and digitally, through wrap-around messaging, peer-to-peer education, and online promotion.

On-Demand Webinar | April 10, 2024

Follow the Patient: How Real-World Data Drives Real-Life Access

This webinar explores how MMIT, powered by NorstellaLinQ, enables pharma teams to use RWD to engage HCPs with timely triggers and improve patient access outcomes.

Article | December 7, 2023

Timing Is Everything: 4 Trends to Bolster Your HCP Marketing Strategy

In the past few years, it’s become more challenging for pharmaceutical companies to promote their products directly to healthcare providers (HCPs), and COVID only exacerbated this trend. Physicians are more selective in who they choose to meet with, and many no longer accept face-to-face meetings with pharmaceutical reps.
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch